STATE STREET CORP - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$243,433
+29.4%
313,500
-50.0%
0.00%
Q4 2022$188,162
+19.1%
627,000
+100.0%
0.00%
Q3 2022$158,000
-11.7%
313,5000.0%0.00%
Q2 2022$179,000
-60.2%
313,500
-10.1%
0.00%
Q1 2022$450,000
+22.3%
348,910
+8.1%
0.00%
Q4 2021$368,000
-25.5%
322,7160.0%0.00%
Q3 2021$494,000
-22.7%
322,7160.0%0.00%
Q2 2021$639,000322,7160.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 57,309$178,0000.03%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 15,552$48,0000.00%
Squarepoint Ops LLC 15,524$48,0000.00%
ExodusPoint Capital Management, LP 11,632$36,0000.00%
BANK OF AMERICA CORP /DE/ 33,215$103,0000.00%
WELLS FARGO & COMPANY/MN 57$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 15,786$49,0000.00%
MILLENNIUM MANAGEMENT LLC 29,233$91,0000.00%
MORGAN STANLEY 54$00.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders